ATNM vs PCAR · rev $35.0M vs P/E 25, rev $33.66B
Actinium Pharmaceuticals Inc (ATNM) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
ATNM currently screens at market cap $33.9M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the ATNM and PCAR stock pages for the full models.
Not investment advice.